Entry Detail



General Information

Database ID:exR0000091
RNA Name:ABI1
RNA Type:mRNA
Chromosome:chr10
Starnd:-
Coordinate:
Start Site(bp):26746593End Site(bp):26861087
External Links:ENSG00000136754



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
B2M
chr15
44711487
44718877
+
RPS27L
chr15
63125872
63158021
-
MTRNR2L1
chr17
22523111
22524663
+
PSMB1
chr6
170535120
170553307
-
COPG1
chr3
129249606
129277773
+
TTF1
chr9
132375548
132406851
-
TCEA1
chr8
53966552
54022456
-
AGK
chr7
141551278
141655244
+
WAC
chr10
28532493
28623112
+
ACLY
chr17
41866917
41930542
-
SUMO3
chr21
44805617
44818779
-
LARP1
chr5
154712843
154817605
+
IL10RB
chr21
33266367
33310187
+
RNF125
chr18
32018825
32073219
+
AFF1
chr4
86935002
87141054
+
PTMS
chr12
6765516
6770952
+
UBE3C
chr7
157138916
157269370
+
THOP1
chr19
2785503
2815807
+
SLC30A5
chr5
69093949
69131069
+
KIF23
chr15
69414246
69448427
+
PAN3
chr13
28138506
28295335
+
CCT4
chr2
61868085
61888671
-
BUB1
chr2
110637528
110678063
-
MTHFD2
chr2
74198610
74217565
+
ARID1A
chr1
26693236
26782104
+
TAF10
chr11
6606294
6612539
-
MYO19
chr17
36495633
36543435
-
SRRM2
chr16
2752626
2772538
+
SRPK1
chr6
35832966
35921342
-
RPLP1
chr15
69452814
69456205
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC091564.7
chr11
6610883
6616594
-
AL158066.1
chr13
52167709
52291557
-
AL355075.4
chr14
20343048
20343685
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.